Proliferation of normal human lymphoid progenitors in cul-
M B lymphocytes,' are continuously generated in the bone marrow. Long term in vitro survival and proliferation of early myeloid' and B-lymphoid3 precursors in the absence of added cytokines requires contact with a bone marrow-derived adherent cell layer, and is regulated by interactions between lymphohematopoietic progenitors and the bone marrow microenvironment: Consistent with these findings is close contact between developing B-iymphoid cells and marrow stroma observed by electron microscopy in bone marrow tissue' and in vitro bone marrow cultures. 6 Cell-cell adhesion is a critical first step in association of B-cell precursors with a supportive microenvironment. The adhesive interaction may allow the B cell to be exposed to high local concentrations of soluble or surface membranebound cytokines or may stimulate cytokine expression in the adherent layer. Human bone marrow-derived fibroblasts (BM-FB), which support the maturation-dependent adhesion of normal B-cell precursor^,^ have recently been shown to promote the survival and proliferation of human B-cell progenitors in vitro.*, ' The adhesion of B-cell precursors to BM-FB is mediated by the integrin molecule VLA-4.'03'' Integrins are a widely expressed family of cell-surface adhesion receptors consisting of heterodimers of (Y and p chains.I2 VLA integrins express ,6 1 chain and any one of at least seven a chains. VLA-4 ( (~4 / @ 1 heterodimer) and VLA-5 (a5/,6 I heterodimer) integrins are expressed by many hematopoietic cells, including normal" and neopla~tic'~ B-cell precursors. Two ligands for VLA-4 have been demonstrated: an Arg-Gly-Asp-independent site on plasma fibronectin (located in the heparinbinding domain), as well as the cell-surface molecule VCAM-1 ,I4 a member of the immunoglobulin superfamily expressed on activated endothelium" and BM-FB." The possible existence of additional VLA-4 ligands is suggested by anti-VLA-a4 antibody-triggered homotypic aggregation of certain cell lines, which is dependent on VLA-4 but not either of the two known VLA-4 ligands. I6 The adhesion of B-cell precursors to BM-FB can be blocked by antibodies to either a 4 or ,61 chain of VLA-4 or served using a combination of blocking antibodies to VCAM-1 and fibronectin. In contrast, NALM-6 adhesion without migration was significantly inhibitable by anti-VCAM-1 antibody. VCAM-1 or fibronectin expression on individual BM-FB did not correlate with NALM-6 migration. These results indicate that the adhesion and migration of human B-lymphoid precursors in the bone marrow microenvironment are mechanistically separable events and suggest the possibility of novel VLA-4 ligand(s), which may be important in human lymphopoiesis. Subpopulations of cells in the bone marrow microenvironment may preferentially support important aspects of lymphoid progenitor development.
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its counterreceptor VCAM-1,lL3l7 but not by antibodies to fibronectin," which is a ligand for both VLA-4 and VLA-5. Anti-VLA-4 antibodies significantly inhibit the proliferation of murine" and human' B cell precursors in vitro. These data suggest that VLA-4-mediated adhesion of human B-cell precursors to BM-FB is a critical step in the development of these cells in their physiologic microenvironment.
Heterogeneity in the bone marrow microenvironment with respect to support of different lymphohematopoietic lineages is suggested by the nonrandom distribution of erythroid," myeloid," and B-lymphoid" precursors in vivo. Growth of myeloid or B-lymphoid progenitors in vitro requires that the bone marrow-derived adherent layer be cultured under conditions suitable for development of one but not the other lineage." The histology of normal bone marrow, differing tissue culture requirements for lymphoid and myeloid growth, and the reciprocal effect of certain cytokines on these lineage^^^.^^ suggest that there may be specific types of adherent cells that support growth of the different hematopoietic lineages. Even within the lymphoid-supportive microenvironment provided by the Whitlock-Witte long-term murine lymphoid culture, B-cell pre-3416 TANG, SCOTT, AND RYAN cursors associate with the polygonal stromal cells and not the more numerous macrophage^.'^ Furthermore, cloned murine stromal cell lines have been shown to differ in their ability to promote particular stages of B-cell precursor devel~p m e n t .~~,~~ Even though the BM-FB layer capable of supporting the earliest stages of human B lymphopoiesis appears to be morphologically homogenous, we hypothesized that subpopulations of these cells may preferentially support the activation and growth of B-cell precursors. This hypothesis is difficult to test with normal B-cell precursors, which are obtainable in small numbers, but precursor B-cell lines, such as NALM-6, can be layered over BM-FB to test for heterogeneous responses by individual BM-FB cells. Bone marrowderived adherent cells are important in promoting in vitro survival of leukemic, as well as normal human B-cell prec u r s o r~.~~ NALM-6 cells not only adhere to, but also migrate beneath the BM-FB layer.z8.29 Migration of adherent cells on an adhesive surface is an energy-requiring second step, which follows the initial adhesion interaction and may be mediated by differing mechanisms. Based on preliminary experiments suggesting that migration of NALM-6 cells in a confluent adherent layer may not be ~niform,'~ we investigated the ability of individual fibroblasts in the adherent layer to support the migration of NALM-6 cells.
We here demonstrate that there is marked heterogeneity of individual BM-FB with respect to supporting the migration of B-cell precursors. In addition, we show that migration of NALM-6 cells under the BM-FB layer is primarily dependent on VLA-4, but neither of the known VLA-4 ligands (VCAM-1, and fibronectin) appears to be primarily involved. These results suggest the presence of spatially segregated microenvironments conducive to activation and migration of adherent B-precursor cells into locations most suitable for their development.
MATERIALS AND METHODS

Cells.
Adherent BM-FB were cultured as described' from bone marrow samples obtained from six normal adult volunteer donors with informed consent. Briefly, light-density cells were cultured in McCoy's 5A culture medium (GIBCO Laboratories, Grand Island, NY) with 10% fetal calf serum (FCS) plus penicillin and streptomycin (100 pg/mL). The nonadherent cells were removed by washing after overnight incubation. Media were changed every 3 days. After incubation for about 14 days, a morphologically uniform layer of long, spindle-shaped cells were formed. The adherent cells were passaged once before seeding into eight-well chamber slides (LabTek; Nunc, Naperville, IL) at approximately 1,000 cells per well. The subconfluent BM-FB, incubated 3 days in eight-well chamber slides, were used for binding experiments. In some experiments, BM-FB were allowed to reach confluence before performance of the adhesion assay. NALM-6 cells were maintained in culture as previously described."
Anti-VLA-a4 chain antibody HP2/ 1 was obtained from AMAC (Westbrook, ME), and L25. Binding assay. To assess adhesion and migration of NALM-6 cells, 50,000 NALM-6 cells were added per well of subconfluent BM-FB (in some experiments, the number of NALM-6 cells per well was varied as described). Cells were incubated at 37°C for 2 hours in McCoy's medium with 10% FCS. After incubation, the supernatant medium and culture wells were removed from the slide containing the BM-FB layer and attached NALM-6 cells. Different wash stringencies were used to distinguish adhesion from migration. Nonadherent NALM-6 cells were removed by a low-stringency wash consisting of dipping the slide three times in a 37°C culture medium. Adherent but not migrating NALM-6 cells were removed by a high-stringency wash consisting of dipping the slide 20 times in a 37°C culture medium. This technique removed weakly adherent NALM-6 cells, but retained morphologically recognizable migrating NALM-6 cells together with the adherent BM-FB layer on the slides. Slides were stained with Wright/Giemsa stain, and the number of BM-FB associated with varying number of NALM- Blocking studies. Adhesion assays of NALM-6 cells to BM-FB were performed as described above in the presence ofblocking antibodies or competitive inhibitors. Reagents were incubated with either BM-FB (anti-VCAM-1 and antifibronectin antibody) or NALM-6 (anti-VLA antibodies and soluble fibronectin 40K fragment) for 30 minutes at room temperature before the adhesion assay. Antibody is added to the cells before mixing to insure that the antibody has an adequate opportunity to bind to its target before the initiation of cell-cell interaction and avoids the complication resulting from initiation of migration before attainment of maximal antibody binding. The final antibody concentration was 3 pg/ mL except for polyclonal antifibronectin antibody (1:40 dilution). The concentration of soluble fibronectin 40K fragment was 100 pglmL. Results were compared with those of wells containing isotype-matched control monoclonal antibody (3 &mL) or polyclonal goat IgG (1:40 dilution).
Immunofluorescence staining. After incubation of NALM-6 with BM-FB for 2 hours at 3 7 T , cells were incubated with mouse anti-ICAM-1, anti-VCAM-1, anti-CD44, or rabbit antifibronectin polyclonal antibody for 30 minutes at room temperature, then washed twice with warm medium. Wells were stained in a similar fashion with FITC-conjugated goat anti-mouse immunoglobulin (for anti-ICAM-I, anti-VCAM-I, and anti-CD44) or F'ITC-conjugated goat antirabbit immunoglobulin (for antifibronectin antibody and its control). After washing with warm medium, the culture chambers were removed from the slide, the cells fixed in l% paraformaldehyde, and then washed twice with phosphate-buffered saline (PBS). A coverslip was placed over the stained cells for fluorescence microscopy analysis.
NALM-6 cells were prepared and added to culture wells containing BM-FB as described above in an eight-well chamber slide. The slide was then placed on a Nikon
Time-lapse video microscopy.
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From
VLA-4-MEDIATED MIGRATION OF 6-CELL PRECURSORS 3 4 1 7
phase-contrast microscope stage equipped with an enclosed incubation chamber at 37"C, and photographed for 2 hours using a video camera connected to a video time-lapse recorder. Microscopic fields (400X) were taped with a frame capture rate of 5 per second. Still video frames showing sequences of migration of NALM-6 cells were captured on a Macintosh I1 computer (Apple, Cupertino, CA) equipped with a video graphics board.
RESULTS
NALM-6 cells preferentially associate with and migrate under subpopulations of BM-FB.
The primary approach used in this study to distinguish adhesion from migration was use of different wash stringency, which discriminates between adherence (low-stringency wash) and subsequent migration events (high-stringency wash). Substantial numbers of NALM-6 cells remained associated with a layer of BM-FB after a low-stringency wash (three washes in medium). We observed by phase-contrast microscopy that some of the attached NALM-6 cells were round and refractile, while others were nonrefractile and spread out, showing cytoplasmic contents including vacuoles ( Fig 1A) . The migrating NALM-6 cells were also distinguishable by Wright/ Giemsa stain ( Fig IB) . The migrating NALM-6 cells appeared larger, with clearly visible cytoplasmic and nuclear structure. After a higher stringency wash (20 washes in medium), only migrating NALM-6 cells remained ( Fig 1C) . The distribution of migrated NALM-6 cells appeared to be distinctively nonrandom with respect to individual BM-FB (Fig 1 D) , whether the BM-FB layer was sparse or confluent (data not shown).
The appearance of NALM-6 cells observed in the process of spreading (Fig I A and B) suggested that the B-cell precursors were spreading as they migrated underneath the cell border of an individual fibroblast. Attachment and migration of NALM-6 cells on the BM-FB layer during the 2-hour incubation were directly observed by time-lapse video microscopy (data not shown). After incubation of NALM-6 cells with BM-FB for approximately 15 to 30 minutes, some NALM-6 cells adjacent to the fibroblast cell border were observed to extend a pseudopod underneath the fibroblast. The portion of the NALM-6 cell inside the cytoplasmic boundary of the fibroblast was observed to flatten as the cell moved underneath the fibroblast. Occasional NALM-6 cells that moved over the top of the fibroblasts were clearly distinguished by the absence of any morphologic shape change as they crossed the cytoplasmic border of the fibroblast. Adherent, but not migrating, NALM-6 cells tended to accumulate around the periphery of the fibroblast. The relationship between NALM-6 cells and BM-FB was dynamic, with constant shuffling of position of the migrating NALM-6 cells underneath the fibroblasts.
To confirm the nonrandom pattern of migration of NALM-6 cells under BM-FB, the number of migrated NALM-6 cells associated with individual BM-FB plated at sparse density was determined. The heterogeneous distribution of migrating NALM-6 on BM-FB is confirmed by statistical comparison of the observed distribution with a random (Poisson) distribution as shown in Fig 2. The expected Poisson distribution was calculated based on the average number of migrated NALM-6 cells per BM-FB. Comparison of the observed distribution with the Poisson distribution showed a highly significant difference (xz = 43,000; P 6
The nonrandom nature of the distribution is especially evident by comparing the number ofexpected BM-FB with no migrating NALM-6 cells (0.4%) with the observed value (29.0% k 1.3 [SDI; n = 3).
As increasing numbers of NALM-6 cells were added in the range of 10,000 to 500,000 per well, the average number of migrated NALM-6 cells per BM-FB increased in a linear fashion up to 200,000 NALM-6 cells, but the distribution of BM-FB with respect to number of migrated NALM-6 cells became progressively even more heterogeneous (data not shown). This is confirmed by the increasing discrepancy between observed and expected percentage of BM-FB with no associated NALM-6 cell, and by the increasing chisquare value associated with comparison of the observed versus random distribution of BM-FB with varying numbers of associated NALM-6 cells (data not shown). There was little increase in average number of associated NALM-6 cells per BM-FB when more than 200,000 NALM-6 cells were added per well, suggesting saturation of the ability of BM-FB to support migration. Even though the NALM-6 cells formed a confluent monolayer over the BM-FB at this number, 23% of BM-FB still failed to support the migration of a single NALM-6 cell. Variability was also observed in the adhesion (without migration) of NALM-6 to individual BM-FB, but there was no correlation between the number of migrated and adherent cells per BM-FB. There was no characteristic morphologic appearance of those BM-FB that supported NALM-6 migration in terms of cell size, shape, or staining characteristics.
The heterogeneous distribution of migrated cells was unlikely to be due to aggregation of the NALM-6 cells, since 93% of NALM-6 cells were in single-cell suspension at the time of addition to the BM-FB layer as assessed by direct microscopic observation. Microscopic analysis of NALM-6 cells incubated for 20 minutes to 2 hours in fresh or BM-FB-conditioned medium showed no significant increase in aggregation. Furthermore, direct observation of migration of NALM-6 cells under BM-FB by time-lapse video microscopy demonstrated that the NALM-6 cells migrated individually, and not as aggregates.
To determine which of the proteins known to mediate adhesion of NALM-6 cells to BM-FB was responsible for NALM-6 migration, inhibition studies with blocking antibodies were performed. Each antibody-blocking study was performed using BM-FB derived from at least three different donors.
Migration of NALM-6 cells on BM-FB was inhibited by blocking antibodies to both VLA-4 subunits (a4 and bl), but neither of the known VLA-4 ligands, as shown in Figs 3 and 4. The association of the few remaining migrating NALM-6 cells with BM-FB in the presence of anti-VLA-P 1 antibody was consistent with a random distribution ( Fig  4B) . As a control for the effect of antibody-binding to the NALM-6 cells, an anti-VLA-PI antibody (8A2), which stabilizes an active VLA conformation but does not block adh e~i o n ,~' did not inhibit migration, but rather caused a
Inhibition of migration by blocking antibodies.
For slight increase (Fig 3) . In contrast, the 8A2 antibody markedly increased migration of NALM-6 on fibronectin-coated plates from 3.6% (~0 . 8 % ; SD) to 17.9% (+2.2%), an increase of 400% (P e .05; triplicate wells). Stimulation of migration of NALM-6 on fibronectin was also observed using a different anti-VLA-PI-stimulating antibody (TS2/1632; data not shown). Anti-VLA-a4 antibodies representative of three epitoperelated groups35 were studied. Antibodies HP2/I (group BI) and L25.3 (group B2) have been shown to block binding of VLA-4 to both known ligands(fibr0nectin and VCAM-1), 35 and both antibodies inhibited migration ofNALM-6 cells to BM-FB (Fig 3) . Treatment with the anti-VLA-a4 antibodies did not reduce migration to the same degree as anti-VLA-PI antibody, resulting in 12% to 22% residual migrating NALM-6 cells compared with control. In contrast to these results, antibody B-5G10 (group C), which does not block binding of VLA-4 to either fibronectin and VCAM-I, did not significantly inhibit migration. Although antibodies of group B2 trigger homotypic aggregation of B-cell lines (including NALM-6; data not shown) via an unknown VLA-4 ligand, the group B2 antibody L25.3 did not enhance, but rather decreased NALM-6 migration.
A blocking anti-VLA-a5 antibody (PI D6) did not significantly inhibit NALM-6 migration when used alone (Fig 5) . However, anti-VLA-a5 antibody significantly decreased residual migration of NALM-6 cells when added with anti-VLA-a4 antibody (Fig 5) . The residual number ofmigrating cells in the presence of anti-VLA-a4 antibody plus anti-VLA-a5 antibody (0.1% of control) was similar to anti-VLA-Bl antibody (0.5% of control).
Antibodies and competitive inhibitors for the two known VLA-4 ligands (VCAM-I and fibronectin) were also studied. Three anti-VCAM-1 monoclonal antibodies were used: 4B9, E1/6, and IGI 1. None of these antibodies blocked NALM-6 cell migration on BM-FB (Fig 3) . 4B9 was shown to be functionally active, since it could block adhesion (but not migration) of NALM-6 on BM-FB by 58.5% (+3.3% SEM; n = 3). E1/6 has been previously shown to block adhesion of normal B-cell precursors to BM-FB."
Polyclonal antifibronectin antibody from two commercial sources did not inhibit migration of NALM-6 cells. The functional blocking ability of each preparation of antifibronectin antibody was confirmed by incubating NALM-6 cell on plastic wells coated with 5 to 10 pg/mL of fibronectin. Adhesion of NALM-6 cells to fibronectin-coated wells was inhibited 93.8% by antifibronectin antibody at the concentration used in the migration assay.
To test further the potential role of fibronectin as a VLA-4 ligand in this assay, a 40-kD heparin-binding fibronectin fragment (FN-40) was used to block migration. FN-40 was shown to have functional blocking ability, since it was able to inhibit adhesion of NALM-6 cells to fibronectin-coated wells in the presence of anti-VLA-5 antibody (to block VLA-%dependent adhesion to the cell-binding fibronectin domain) by 39%. However, FN-40 was incapable of inhibiting migration of NALM-6 cells under BM-FB (Fig 3) .
To test the possibility of VCAM-1 /fibronectin ligand cooperation, cultures were treated with both anti-VCAM-l (4B9) and antifibronectin antibodies. These antibodies caused a small, but reproducible inhibition of NALM-6 migration (12. l t 2.6% reduction compared with control; Fig  3) . These results were consistent with an experiment using a combination of anti-VCAM-1 (4B9) antibody and FN-40, which inhibited migration by 9.690.
Correlation of migration with expression of adhesion molecules by BM-FB. To evaluate further the possible involvement of VCAM-1, fibronectin, or other adhesion ligands in mediating the heterogeneity in migration of NALM-6 cells underneath BM-FB, the surface marker expression by individual BM-FB was correlated with the number of migrating NALM-6 cells. VCAM-1 was expressed to a variable degree by most BM-FB. Staining with antifibronectin antibody was more intense, but also varied among BM-FB. However, the number of migrating NALM-6 cells did not correlate with the intensity of VCAM-1 or fibronectin expression on individual fibroblasts as assessed by fluorescence microscopy. ICAM-1 expression was undetectable by indirect immunofluorescence. Expression of CD44 by BM-FB was intense and relatively uniformly distributed among BM-FB.
DISCUSSION
Interactions between B-cell precursors and a supportive bone marrow-derived adherent layer are critical for normal B-cell lymphop~iesis.~ The human B-cell precursor cell line NALM-6 has been shown by Miyake et aIz8 to attach to and migrate underneath layers of cloned murine stromal cells. We here demonstrate that NALM-6 cells also migrate underneath human BM-FB, cells that have been shown to support the in vitro proliferation of human lymphoid progenitor cells.' The BM-FB adherent layers were prepared under conditions (10% FCS; no hydrocortisone) that result in a morphologically uniform layer of long, spindle-shaped cells. Adipocyte differentiation was not observed in our BM-FB layer, and the proportion of cells with macrophage-like appearance was low in the subconfluent cultures (adipocytes and macrophage-like cells develop in human bone marrowderived adherent layers under Dexter-type culture conditions). The fibroblast origin of the BM-FB layer was supported by histochemical and immunofluorescence data.36 Despite their uniform morphologic appearance, BM-FB varied markedly in their ability to attract the migration of NALM-6 cells, even in the presence of excess numbers of NALM-6 cells. The migration of NALM-6 cells was primarily dependent on VLA-4, with lesser involvement ofVLA-5. However, migration could not be inhibited by multiple blocking antibodies or reagents to either ofthe known VLA-4 ligands, nor was migration associated with variation of VCAM-1 or fibronectin expression among individual fibroblasts.
The morphologic appearance of NALM-6 cells that remain after stringent wash conditions is similar to the classical spreading of cells on a surface. However, using timelapse video microscopy, it became apparent that, under our assay conditions, NALM-6 cells do not assume the "spread" morphology unless they are also migrating underneath BM-FB. Therefore, we use the term "migration" for the movement of NALM-6 cells under BM-FB. Adherent but not aigrating cells can be distinguished morphologically from cells that have migrated underneath the BM-FB layer by phase-contrast microscopy (Fig 1 A) , histochemical staining (Fig 1 B) , time-lapse video microscopy (data not shown), and functional adhesion assays using different wash stringencies (Fig IB and C) . The NALM-6 cells that have migrated beneath the BM-FB layer cannot be washed off unless the fibroblast layer is disrupted. The video time-lapse studies show that the NALM-6 cells do not spread on top of the fibroblast layer or pass through the fibroblasts (empiripolesis), but approach the fibroblast's cytoplasmic border and migrate underneath the edge of the cell. The dynamic nature of B cell-fibroblast interaction is illustrated by the constant movement of migrating NALM-6 cells, with frequent extension of cell processes and shape changes. The accumulation of NALM-6 cells under the BM-FB adherent layer is reminiscent of "cobblestone" areas of lymphoid precursor cells burrowed underneath the adherent layer, as observed in murine lymphoid culture system^.^' Migration of B-cell precursors to the underside of the fibroblasts contrasts with the relative lack of adherent or migrating cells on the fibroblast surface. This suggests the presence of chemotactic factors or specialized adhesion ligands in a polarized distribution on the fibroblast, similar to the recently reported polarized distribution of ligand for adhesion of aE/ &expressing intestinal intraepithelial lymphocyte^.^^
The marked variability in ability of BM-FB to induce migration of B-cell precursors under their cytoplasmic border was unexpected in light ofthe monomorphic appearance of the fibroblast layer. This variability was a consistent observation whether the BM-FB were tested at confluence or in sparsely seeded wells. The degree of heterogeneity observed in the distribution of migrating NALM-6 cells per BM-FB did not decrease as more NALM-6 cells were made available to the BM-FB layer, but in fact increased markedly. This is most clearly demonstrated by the comparison of chi-square values and expected versus observed percentage of BM-FB with no associated migrating NALM-6 cells. Even when saturating numbers of NALM-6 cells were added, a significant number of BM-FB were unable to support the migration of a single NALM cell. Under these conditions, more than 40 cells could be seen to have migrated underneath an individual fibroblast in the same well in which significant numbers of fibroblasts had no associated migrating NALM-6 cells at all. The degree of heterogeneity observed in our system may be greater than previously observed,28 possibly due to our use of normal human bone marrow fibroblasts at second passage to preserve as much of the physiologic heterogeneity of the in vivo bone marrow microenvironment as possible.
The possibility that the heterogeneity lies only in the NALM-6 cells as opposed to the BM-FB is unlikely, since this would not give rise to variation in migration associated does not block, but rather causes a slight increase in migration. The involvement of VLA-5 is less significant, but VLA-5 does appear to mediate a minor component of NALM-6 migration that is not inhibitable by anti-VLA-4. The blocking ability of anti-VLA-a4 and -a5 antibodies is roughly proportional to the quantitative expression of these two integrins on B-cell precursor lines." The involvement of other VLA molecules is unlikely, since the combination of antLa4 and a n t i d antibodies inhibits as effectively as anti-81. Our findings differ from those of Miyake et aI2* in that we show effective blocking of migration by antLa4 antibodies alone. This discrepancy may be related to our use of early-passage normal human bone marrow fibroblasts as opposed to a murine stromal cell line. Our results are similar to the data of Miyake et al in demonstrating a role for both VLA-4 and VLA-5 in migration of B-cell precursors.
Although the integrin a4187 has a functional role in Peyer's patch-specific lymphocyte homing and is capable of this molecule is unlikely to be involved in NALM-6 migration. Blocking experiments showed that anti-Dl antibody could completely inhibit the migration of NALM-6 cells. Furthermore, by flow-cytometnc analysis, the surface expression on NALM-6 cells of Dl was similar to that of a 4 plus 015.' ' Based on previous results with adhesion of normal B-cell precursors to BM-FB,"*" it was expected that one ofthe two known VLA-4 ligands, VCAM-1, would play a major role in mediating VLA-4-dependent migration of NALM-6 cells under BM-FB. VCAM exists in two variant forms, resulting from alternate mRNA splicing. 40 The major form of VCAM-1 (VCAM-7D) has seven extracellular immunoglobulin-like domains, of which the three NH2-terminal domains (domains l through 3) are similar in amino acid sequence to domains 4 through 6.4' It has been shown that either domain 1 or the homologous domain 4 is required for VLA-4-dependent adhesion. Either of these binding sites can function in the absence of the other. Of the three anti-VCAM antibodies that were used in this study, 4B9 is capable of blocking both domains 1 and 4.4' Elf6 can bind only one of the domains (4 or 1) and, therefore, its functional blocking activity may be slightly lower than that 0f4B9.~' In our experiments, none of the three anti-VCAM-1 antibodies (4B9, E1/6, and 1G1 l), caused significant inhibition of migration on their own. The functional blocking capability of the antibodies 4B9 and E 1/6 in our hands is shown by the ability of 4B9 to block NALM-6 adhesion (but not migration) on BM-FB and the blocking ability of Elf6 on adhesion of normal human CDIO+ B-cell precursors to BM-FB." The ability of 4B9 to clearly inhibit NALM-6 adhesion, but not migration under the BM-FB layer, further suggests that adhesion and migration are two mechanistically separable events. The lack of correlation between the number of migrating and adherent NALM-6 cells on individual BM-FB is also consistent with different mechanisms for the adhesion and migration of B-cell precursors.
The lack of involvement of VCAM-1 in NALM-6 migration has been previously suggested," but the role of the other known VLA-4 ligand, fibronectin, has not been tested. We found that antifibronectin antibody and a soluble fibronectin 40K fragment did not inhibit NALM-6 cell migration. However, there was a modest reduction in migration when anti-VCAM-l monoclonal antibody (4B9) and antifibronectin antibody or FN-40 were added together, which was quantitatively consistent with the amount of VLA-5-dependent migration observed in the presence of antLa4 antibody. Further evidence supporting the lack of a primary role for the two known VLA-4 ligands is the absence of correlation of NALM-6 migration with expression of fibronectin or VCAM-I by individual BM-FB. Finally, the anti-VLA-fi I-activating antibodies 8A2 and TS2/ I6 did not substantially increase NALM-6 migration under BM-FB, although they were capable of markedly upregulating the migration of NALM-6 cells on fibronectin, consistent with a previous report!2
Although these data strongly suggest that fibronectin does not play a major role in mediating NALM-6 migration under BM-FB, it is possible that conformational changes or posttranslational modification of fibronectin in the extracellular matrix, or exclusion of neutralizing antibody from the space underlying the BM-FB, may prevent its recognition by antifibronectin antibody. The effective concentration of fibronectin in the extracellular matrix and its relative accessibility to neutralizing antibody could also affect the degree of inhibition by blocking reagents.
A third class of VLA-4 binding sites has been postulated based on VLA-4-dependent, but VCAM-1 -and fibronectin-independent homotypic aggregation of lymphoma cell lines caused by certain anti-VLA-a4 a n t i b~d i e s . '~,~~ The significant inhibitory effect on NALM-6 migration caused by the aggregating anti-VLA-a4 antibody L25.3 is evidence against a primary role of these VLA-4 ligands in this system. Further evidence against this hypothesis is that the anti-VLA-a4 antibody B5G10, which is able to block VLA-4-mediated homotypic aggregation (but not VLA-4 adhesion mediated through VCAM-1 or fibronectin) was unable to inhibit NALM-6 migration. Together, these findings suggest that this uncharacterized class of VLA-4 ligand(s) is not primarily responsible for NALM-6 cell migration.
Our observations suggest the presence of an unexpected degree of functional heterogeneity in a lymphoid-supportive microenvironment with respect to migration of B-cell precursors. The adhesion protein responsible for migration in this system is primarily VLA-4, with a minor contribution by VLA-5. Identification of the chemotactic stimulus for NALM-6 migration would provide important insights into the characteristics of the lymphoid-supportive microenvironment that may underlie the observed heterogeneity among cells in the adherent layer. Our studies further suggest the possibility of novel VLA-4 ligand(s) that may be important in human lymphopoiesis. Heterogeneity in expression of VLA-4 ligands or chemotactic factors by subpopulations of cells in the bone marrow microenvironment may represent potential mechanisms for spatial localization of lymphoid-and myeloid-supportive environments.
